50 Successful Marketing Applications
Since 1988
50+ Successful
Marketing Applications
A History of Impact in Drug Development
Mind the Gap(s): Early Identification of Issues is Key for a Successful NDA or BLA
New Webinar Series
previous arrow
next arrow
Slider

Service Solutions

Cato Research, Your Reliable Partner

Cato Research (CATO) is an international regulatory and clinical contract research organization (CRO) that has been delivering successful outcomes for its clients since 1988. Through highly qualified and experienced personnel located in offices across North America, Europe, Israel, and South Africa, supported by strategic alliances with selected regional CROs, CATO offers tried-and-trusted international coverage.

CATO has the advantage of integrated regulatory, clinical, and scientific expertise. Our highly talented and experienced international team offers services from preclinical through IND (or equivalent), clinical development, and marketing approval to Phase 4 postmarketing research. Our track record includes successes across many different health products, including drugs, biologics, vaccines, cell therapies (including stem cells), nutriceuticals, medical foods, devices, and diagnostics. In terms of diseases and indications, CATO has been involved in a wide variety of projects with a dominant focus in oncology, neurology/CNS, and rare and orphan drug indications. This experience includes leadership of, and involvement in some of the most challenging and innovative products.

Therapeutic Expertise

What our Sponsors say about us...

Very impressed with the quality and efficiency that Cato…

"I’m very impressed with the quality and efficiency that Cato put into the protocol. Kudos for your team. I am hoping that we will have more collaboration with you in the near future, not only for NDA, but for other technical writing projects."

- Vice President of Medical, Southeast Pharmaceutical Company

2019-11-08T15:45:27-05:00

- Vice President of Medical, Southeast Pharmaceutical Company

"I’m very impressed with the quality and efficiency that Cato put into the protocol. Kudos for your team. I am hoping that we will have more collaboration with you in the near future, not only for NDA, but for other technical writing projects."

“…Thanks to all of you!

"...Thanks to all of you!  You guys are terrific!  It's a real pleasure to work with you.  Thanks to all the efforts and professional work.  Looking forward for the next phase on this project!
Please find attached the APPROVAL letter for Product.  Please share in our excitement as you have been partners in this adventure!"

Global U.S. Biotechnology Company

2017-11-21T21:08:17-05:00

Global U.S. Biotechnology Company

"...Thanks to all of you!  You guys are terrific!  It's a real pleasure to work with you.  Thanks to all the efforts and professional work.  Looking forward for the next phase on this project! Please find attached the APPROVAL letter for Product.  Please share in our excitement as you have been partners in this adventure!"

Upcoming Events

No event found!

Cato Research Blog

  • New FDA Guidances for October 2019 and Upcoming...
    by Cato Research on November 6, 2019 at 3:09 pm

    By Sheila Plant, PhD, MHS, RAC (US), Director, Regulatory Strategy at Cato Research Special Interest Guidances/Information Date Posted Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 – Draft Guidance 01 November 2019 Chronic Hepatitis D Virus Infection: Developing Drugs for […]

  • What’s New Health Canada? August and September...
    by Cato Research on October 18, 2019 at 1:19 pm

    What’s New Health Canada? By Christine Straccini, B.Sc., C.C.R.P., Regulatory Associate What’s New in: Therapeutic Products Directorate: Biologics and Genetic Therapies Directorate: Medical Devices: […]

Twitter @CatoResearch

LinkedIn Cato Research

Facebook @catoresearch

Searching for something else?